Background--Omega-3 polyunsaturated fatty acids (x3 PUFAs) suppress inflammation through activation of free fatty acid receptor 4 (FFAR4), but this pathway has not been explored in the context of cardiovascular disease. We aimed to elucidate the involvement of FFAR4 activation by x3 PUFAs in the process of vascular inflammation and neointimal hyperplasia in mice.
for long-chain fatty acids including x3 PUFAs, has attracted widespread attention based on evidence of FFAR4 mediating anti-inflammatory and insulin-sensitizing activity. 13 Animal models and human studies show that FFAR4 modulates food intake and body weight gain, adipocyte differentiation, and obesity. 14 Consequently, many reports have focused on the antiobesity and chronic inflammation-dampening effects elicited by activation of FFAR4. 15-18. Obesity-related cardiovascular disorders involve complex inflammatory cascades with infiltration of monocytes and macrophages and other inflammatory cells and initiation of neointimal hyperplasia. 19, 20 Adipose tissues play important roles in the crosstalk with their neighbor organs, including blood vessels, kidney, and heart, with perivascular adipose tissue (PVAT) being important in vascular inflammation. 21 Early evidence has shown that FFAR4 is expressed in both macrophages and adipose tissue 13, 14 ; therefore, targeting FFAR4 to ameliorate inflammation and obesity, and perhaps also vascular diseases, is expected as a potential novel therapeutic strategy.
Surprisingly, very little has been published related to the cardiovascular effects relevant to x3 PUFA-FFAR4 signaling.
In the present study, we aimed to elucidate the involvement of FFAR4 activation by x3 PUFAs in the process of arterial thrombosis and neointimal hyperplasia in mice. We used transgenic fat-1 mice, capable of generating significant amounts of x3 PUFAs from x6 PUFAs, 22 and compound fat-1/FFAR4 knockout mice together with laser Doppler and ultrasound imaging across several cardiovascular injury models to examine the role of the x3 PUFA-FFAR4 pathway. We found that endogenously generated x3 fatty acids in fat-1 mice mitigate arterial damage-initiated thrombus formation and neointimal hyperplasia and may exert beneficial cardioprotective actions by activation of FFAR4.
Methods

Generation and Breeding of FFAR4 Knockout and fat-1 Mice
The Ffar4 À/À mouse strain on a C57BL/6 genetic background used for this research project was created from an embryonic stem cell clone (15078A-A9) generated by Regeneron Pharmaceuticals, Inc and made into live mice by the Knockout Mouse Project Repository and the Mouse Biology Program at the University of California Davis. Methods used to create the VelociGene targeted alleles have been published. 23 Briefly, the Ffar4 gene, including exons 1 to 3, was disrupted by gene targeting with a vector (ZEN-UB1) containing a reporter lacZ and a selection cassette (neomycin) driven by the promoter from the human ubiquitin C gene and flanked with 2 loxP sites.
Fat-1 breeders on a C57BL/6 background were provided by Dr Jing X. Kang (Harvard Medical School) . In this study, fat-1 mice were crossbred with FFAR4 knockout mice over 2 generations to obtain the compound Ffar4 À/À /fat-1 hemizygous transgenic mice. The fat-1 and Ffar4 genotypes of each mouse were confirmed by polymerase chain reaction (PCR) using tail genomic DNA after weaning and again after euthanization. Primers used for FFAR4 knockout mice: common reverse, with these primers was 250 base pairs in size. 24 All mice were housed ≤4 mice per cage in a temperatureand humidity-controlled animal facility with a 12-hour light/ dark cycle. Food and water were available ad libitum. All mice were maintained after weaning on a modified AIN-76A rodent diet (D11122101; Research Diets) containing 10% corn oil (22 kcal percentage of fat), which is high in linoleic acid (18:2 x6) and has trace levels of a-linolenic acid (18:3 x3). Both male and female 4-week-old mice were housed individually, and body weight and food intake were recorded twice weekly until mice were 12 weeks old. Food intake per mouse per day was averaged weekly over the course of 8 weeks. In another set of experiments, mice (18 to 22 weeks old) maintained on the modified diet were euthanized. The liver and white adipose tissues from subcutaneous (extending from the dorsolumbar area to the inguinal area), epididymal (male), periuterine (female), and perirenal regions were excised and weighed. All procedures for animal experimentation were undertaken in accordance with the principles and guidelines of the Canadian Council on Animal Care and were approved by the Queen's University animal care committee.
X-Gal Staining
Expression of active b-galactosidase from the lacZ gene driven by the Ffar4 promoter allows the use of 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-gal) staining as a surrogate for native sites of FFAR4 expression in Ffar4 À/À mice. Stomach, small intestine, colon, adipose tissues (subcutaneous and perirenal), perivascular adipose tissue (PVAT) surrounding the abdominal aorta, and brown adipose tissue (interscapular) from both WT and Ffar4 À/À mice were dissected and fixed for 15 minutes in cold 2% paraformaldehyde/0.2% glutaraldehyde. X-gal staining was performed at 37°C in PBS containing 2 mmol/L magnesium chloride, 5 mmol/L potassium ferrocyanide trihydrate, 5 mmol/L potassium ferricyanide crystalline, 1 mg/mL X-gal, and 2.5% dimethyl sulfoxide. WT tissues were used as negative controls for endogenous b-galactosidase activity. Color changes were observed every 30 minutes for the first 5 hours and then left overnight. Stained tissues were rinsed in PBS and then photographed using a digital camera (Q-Color5; Olympus Corp) under the stereomicroscope (MZ16; Leica Microsystems Pty Ltd).
In the case of X-gal staining of lung sections and arteries (carotid, thoracic, and abdominal aortic), tissues were fixed for 10 to 15 minutes and snap frozen in optimal cutting temperature medium with liquid nitrogen. Sections were cut and stained with X-gal overnight in a humidified chamber at 37°C. After brief rinses with PBS and distilled water, sections were counterstained with Nuclear Fast Red, then air dried and mounted with Cytoseal 60 medium (Richard-Allan Scientific). Visualization was performed with a microscope (Leica).
Determination of x3/x6 Fatty Acids
Fatty acid profiles of 12-week-old mouse tails were analyzed by gas chromatography, as described previously. 24, 25 Briefly, each mouse tail sample (%0.5 cm) was homogenized and extracted, and fatty acid methyl esters were prepared using 14% boron trifluoride in methanol. Sealed samples were stored at À20°C until further analysis was performed. Gas chromatography (Shimadzu GC-17A) with flame ionization detection and capillary column (HP-Innowax, 19091N-113; HP Agilent) was used to analyze fatty acid methyl esters. Gas chromatography standard (GLC 461; Nu-Chekprep Inc) was used to identify fatty acid methyl esters. Values are expressed as an area percentage of total measured fatty acids. After mice were euthanized by CO 2 , blood was collected by cardiac puncture and allowed to coagulate at room temperature. Following overnight storage at 4°C, serum was obtained by centrifugation at 2000g for 5 minutes and kept at À80°C. Fatty acids including arachidonic acid, EPA, and DHA in serum were determined by liquid chromatographymass spectrometry analysis, as described previously. 26, 27 Femoral Artery Thrombosis and Laser Doppler Tissue Perfusion Imaging
Mice aged 10 to 12 weeks were used, and hair was gently removed using a combination of mechanical shaving and chemical depilation the day before surgery. Briefly, the left femoral artery was exposed by blunted dissection under ketamine (150 mg/kg) and xylazine (10 mg/kg, intraperitoneal) anesthesia. A piece of filter paper (193 mm) soaked in 10% FeCl 3 was applied in contact with the adventitial surface of the vessel. After 5-minute exposure, the filter paper was removed, and the vessel was washed with sterile normal saline. A MoorLDI laser Doppler imager (Moor Instruments) was used to measure the relative perfusion units in hind limb before (preinjury) and after surgery (postinjury at 0, 30, 60, and 90 minutes). 28, 29 The mice were put on a warm pad during this process, under anesthesia, and were euthanized by cervical dislocation immediately after conclusion of the experiment when the animals were still under deep anesthesia. We assessed the mean blood perfusion units in comparison with the nonischemic limb (right) from the same animal to minimize positional and uncontrollable field differences. Mean relative perfusion units for the ischemic limb (left) were measured in an offline mode and are presented as percentages relative to the preinjury RFU.
Chronic FeCl 3 Injury Model and Ultrasound Examination of Common Carotid Artery
The right common carotid artery (CCA) injury was induced by FeCl 3 , as described previously with some modification. 30, 31 Briefly, analgesia was administered (20 mg/kg tramadol [Ultram; Chiron AS]) at least 1 hour prior to surgery in mice aged 8 to 10 weeks. Mice were then anesthetized with 1% isoflurane by nose cone. The right CCA was exposed with minimal dissection. A 193-mm piece of filter paper soaked in 5% FeCl 3 solution was placed on the adventitia of the CCA for 5 minutes. The external surface of the artery was then washed with normal saline, and the skin was closed and sutured, followed by subcutaneous administration of 1.0 mL of warm normal saline solution. Mice were returned to their cages once fully mobile. The entire procedure was performed on a heated pad. All animals recovered and showed no signs of a stroke. Postoperative care, including separate caging and continuous monitoring, was provided. The carotid artery ultrasound examination was performed by a Vevo 770 in vivo microimaging system (VisualSonics). Ultrasound images were obtained by an RMV 704 scanhead in mice 1 day prior to surgery (as a baseline) and followed by weekly ultrasound measurements for 4 weeks after surgery. Mice were anaesthetized using 1% isoflurane delivered by nose cone. Hair around the neck was removed using a combination of mechanical shaving and chemical depilation, and mice were placed on a heated platform in a supine position. Rectal temperature and electrocardiogram were monitored throughout the procedure. The B-mode image was used as a guide to obtain M-mode and pulsed wave Dopplermode images. Mean systolic luminal diameter of the right CCA was measured at %1 mm below the carotid bifurcation using the M-mode image, whereas the flow-velocity curve was measured with the pulsed wave Doppler-mode image. From the flow-velocity curve, mean velocity was obtained. Blood flow (mm 3 /s) was calculated as mean velocity9pr 2 9cosh (r indicates radius equal to mean luminal diameter/2; h indicates Doppler beam angle against the blood flow). Multiple measurements were made for each parameter, with an average of 3 to 5 cardiac cycles used for all calculations. One day after the last ultrasound imaging (at 28 days after FeCl 3 injury), the mice were euthanized by CO 2 and were perfused through the left ventricle with ice-cold PBS. Both CCAs (right, affected; left, unaffected) were carefully harvested and embedded in blue frozen section compound (VWR) for immunohistochemistry and for hematoxylin and eosin staining.
Histological and Immunofluorescence Staining
CCAs were cut (6 lm) and histologically stained routinely with hematoxylin and eosin for morphological analysis. Stained sections were photographed using a microscope (Leica). As described previously, 30 
RNA Extraction and Quantitative or Reverse Transcription PCR
Aortic smooth muscle from 3 mice of each strain was dissected and pooled, as per the protocol used previously in our laboratory. 34 Peripheral lymphocytes were isolated by Lympholyte medium (CL5110; Cedarlane). WT lung endothelial cells were isolated by enzymatic digestion 35 and grown in endothelial cell basal medium-2 (CC3156; Lonza) with the supplement of growth factors (CC-4147; Lonza). Endothelial cells were then subjected to fluorescence-activated cell sorting using a fluorescein isothiocyanate-conjugated Griffonia simplicifolia IB 4 isolectin antibody with a Beckman Coulter EPICS Altra flow cytometer. 35 Total cellular RNA was extracted from various tissues or cells using the RNeasy Mini Kit (catalog no. 74104; Qiagen), according to the manufacturer's instructions. After treatment with DNase I, RNA quantity was assessed using a Nanodrop N-1000 spectrophotometer (Nanodrop). 36 Total RNA (1 lg) was reverse transcribed to cDNA using the iScript kit (BioRad), according to the manufacturer's protocol. Quantitative PCR was performed using a thermal cycler (Applied Biosystems Model 7500) with SYBR Green PCR master mix (BioRad). GAPDH was used as a control housekeeping gene. Melting curves were performed on completion of the cycles to ensure absence of nonspecific products. Oligonucleotide primers were acquired from Eurofins MWG Operon and are listed in Table 1 . Data were calculated using the 2 ÀDDCT method and are presented as fold-induction of transcripts for target genes normalized to GAPDH, with respect to controls. 15 
Data Analysis
Data are expressed as meanAESEM. The Kolmogorov-Smirnov test was used as a normality test. One-way ANOVA analysis was used for normally distributed variables, and the Tukey honestly significant difference post hoc comparisons were conducted when the ANOVA indicated a significant difference among the compared means. Nonparametric Kruskal-Wallis tests were used for non-normally distributed variables. Repeated measures of postbaseline body weight, food consumption, relative blood flow in hind limbs, and luminal diameter/blood flow of right CCA were analyzed by use of a general linear model followed by Tukey honestly significant difference post hoc comparisons. Tests were 2-tailed, and values of P<0.05 were considered statistically significant. The statistical analysis was performed with IBM SPSS Statistics 19 software (IBM Corporation), and the data were plotted by GraphPad Prism 6 software (GraphPad). ( Figure 1A ). Using reverse transcription PCR, quantitative PCR, and X-gal staining from the b-galactosidase reporter, which represents native sites of FFAR4 expression, we found that FFAR4 is highly expressed in gastrointestinal tract, lung, and various adipose tissues and resident peritoneal macrophages ( Figure 1C and 1D) , consistent with previously published results. 14, 37 FFAR4 knockout mice were crossbred with fat-1 mice 22 to obtain compound Ffar4 À/À /fat-1 mice. Gas chromatography and liquid chromatography-mass spectrometry results showed a shift in the x6/x3 PUFA ratio in transgenic fat-1 and compound Ffar4
À/À /fat-1 mice compared with mice without the fat-1 transgene (Table 2; Figure 2 ) when they were placed on a special diet rich in x6 fatty acids. The results indicated lower levels of x6 polyunsaturated acids (arachidonic acid) and more abundant x3 fatty acids (alinolenic acid, DHA, EPA, and docosapentaenoic acid) in transgenic fat-1 mice (both fat-1 and Ffar4
À/À /fat-1 mice).
The transgene fat-1 enables endogenous x3 PUFA synthesis from x6 PUFA via a x3 fatty-acid desaturase enzyme 38 ;
however, there was no difference in fatty acid profiles between WT and Ffar4 À/À mice or between fat-1 and
Ffar4
À/À /fat-1 mice. This indicates that any phenotypic differences observed between fat-1 and Ffar4 À/À /fat-1 mice are most likely the result of loss of murine FFAR4 expression. We carried out all subsequent studies using 4 strains of mice:
(1) control C57BL/6, WT; (2) mice capable of forming significant amounts of x3 PUFA, fat-1; (3) FFAR4 knockout, Ffar4
À/À
; and (4) compound Ffar4 À/À /fat-1.
Body weight was similar in both WT and FFAR4-deficient groups of mice on the x6 PUFA-rich diet; however, the body weight of mice with the fat-1 transgene (fat-1 and compound Ffar4 À/À /fat-1) versus without fat-1 (WT and Ffar4 À/À ) was slightly less in mice aged %6 to 10 weeks but not in old mice, aged %20 weeks ( Figure 3A , 3B, and 3E), which is consistent with a previous report in fat-1 mice. 39 On the x6 PUFA diet, no significant differences in food intake were observed between the 4 groups of male and female mice ( Figure 3C and 3D). FFAR4 plays a critical role in adipose tissue homeostasis including regulation of adipocyte differentiation and lipogenesis. 14 We measured the weights of several adipose depots, which showed that white adipose tissues (subcutaneous, epididymal/periuterine, perirenal) were heavier in older FFAR4 mutant mice (aged 18 to 22 weeks) than those in their counterparts, with no difference in liver weights when fed the x6 PUFA diet ( Figure 3F ). This is consistent with a previous report in mice fed a high-fat diet. Figure 4A ). X-gal staining of lung sections revealed that FFAR4 is seen in epithelial cells of bronchi and bronchioles but not in accompanying vessels ( Figure 4B ). Using reporter gene staining, FFAR4 is also highly expressed in PVAT of carotid, thoracic, and abdominal aorta arteries, with much weaker expression in vascular smooth muscle cells and lymophocytes ( Figure 4C ). FFAR4 was not found in platelets using X-gal staining and Western blot analysis (data not shown). Consequently, these vascular-specific FFAR4 expression patterns should provide insight into how FFAR4 regulates the complex interactions between vascular and perivascular cells (adipocytes and macrophages) in the context of inflammation.
x3 Fatty Acids Mitigate Femoral Artery Thrombosis via FFAR4
Localized vascular (femoral artery) application of FeCl 3 causes major oxidative stress with the generation of free radicals, leading to lipid peroxidation, destruction of endothelial cells, and occlusive thrombus formation. 40 Initiation of thrombus caused a significant decrease in blood flow of the affected left hind limb in all 4 groups. WT mice (n=9) showed a decrease (51AE8% versus preinjury) in blood flow at 30 minutes after FeCl 3 injury, and this was maintained until the end of the experiment at 90 minutes (39AE7% versus preinjury). Postinjury blood flow in fat-1 mice (n=9) dropped less compared with WT mice at 60 and 90 minutes, with blood flow greater relative to WT littermates (74AE13% and 80AE13%, respectively; P<0.05 versus WT) ( Figure 5 ). Change in blood flow was not statistically significant versus WT in Ffar4 À/À mice (n=7), and flow in Ffar4 À/À /fat-1 (n=9) mice decreased after 30 minutes and was maintained until 90 minutes but showed a significant decline at 90 minutes compared with fat-1 mice (both P<0.05). Blood flow did not vary among any of the experimental groups in the nonischemic right limb. These results provide evidence that endogenously generated x3 fatty acids mitigate arterial damage-initiated thrombus formation and may exert beneficial cardioprotective actions via activation of FFAR4.
FFAR4 Interplays With x3 Fatty Acids to Suppress Neointimal Hyperplasia
Next, we investigated the effects of x3 fatty acids on longterm FeCl 3 arterial damage-induced vascular inflammation and neointimal hyperplasia in the CCA. Ultrasonographic assessment at the bifurcation of the right carotid artery showed that luminal diameter did not differ significantly between the 4 groups at baseline; however, the luminal diameter in WT mice decreased significantly at 1 week after injury. This phenomenon persisted in both Ffar4 À/À and
Ffar4
À/À /fat-1 mice from 1 to 4 weeks but not in fat-1 mice, whose CCA luminal diameter was greater than that of WT and Ffar4 À/À /fat-1 mice (P<0.05) ( Figure 6A and 6C) . In accordance with luminal diameter data, blood flow detected by pulsed wave Doppler of fat-1 mice showed significant elevation versus mice in the other 3 groups (WT, Ffar4 À/À , and Ffar4 À/À /fat-1) ( Figure 6B and 6D). These data indicate that the absence of FFAR4 results in loss of beneficial actions exerted via x3 PUFAs. Representative hematoxylin and eosin-stained CCA sections of normal control vessels and FeCl 3 -injured arteries showed distinct morphological changes at 28 days with a large neointima composed of smooth muscle cells ( Figure 7A and 7B), which is consistent with a previous study. 31 A smooth muscle cell-rich neointima (a-smooth muscle actin positive) lined with CD31-positive endothelial cells was observed at 28 days after FeCl 3 injury in all 4 groups of mice ( Figure 7C through 7E). Intima:media ratio determination, the main parameter for evaluating neointimal hyperplasia, revealed that fat-1 mice had a lower intima:media ratio than the other 3 groups of mice ( Figure 7F ). This indicates that FeCl 3 arterial injury led to neointimal hyperplasia, which can be markedly reduced by x3 PUFA in fat-1 mice through an FFAR4-dependent mechanism.
x3 Fatty Acids Dampen Vascular Inflammation Through FFAR4 Pathways
Growing evidence suggests that white PVAT (eg, surrounding carotid artery) can support vascular inflammation via macrophage accumulation and secretion of adipokines. 21, 41, 42 Along with the neointimal hyperplasia results, we found increased macrophage infiltration into both the neointima ( Figure 8A ) and the PVAT ( Figure 8B ) using immunohistochemistry (CD68 staining) in sections from injured CCA compared with unaffected CCA (data not shown). FFAR4 activation by x3 PUFAs decreases adipose tissue macrophage infiltration and reduces proinflammatory gene expression. 13 Consistent with these findings, there was a substantial decrease in positively labeled macrophages in fat-1 mice (7AE1/10 4 lm 2 ) versus WT mice (26AE4/10 4 lm 2 , P<0.01), but there was no effect in Ffar4 À/À /fat-1 mice ( Figure 8C ).
Discussion
Although it has long been accepted that x3 PUFAs reduce the risk of cardiovascular disease, 6 some clinical studies have shown conflicting results, 11, 12, 43 provoking considerable debate about the efficacy of x3 PUFAs in the management of heart disease. In this study, using a novel compound transgenic mouse model (Ffar4 À/À /fat-1) that makes x3
PUFAs endogenously but lacks FFAR4, we found a potential mechanism involving FFAR4 signaling by which x3 PUFAs can dampen vascular inflammation, attenuate neointimal formation, and suppress arterial thrombosis. For the first time, we demonstrated compelling evidence for strong FFAR4 expression in perivascular cells (adipocytes and macrophages) with weaker expression in vascular smooth muscle cells and lymphocytes and no detectable expression in platelets and endothelial cells. The high expression in PVAT and macrophages prompted us to consider the involvement of these cells in the context of an "outside-in" signaling model of vascular inflammation.
Cardiovascular inflammation, involving infiltration of monocytes and macrophages and other inflammatory cells, plays a central role in mediating obesity-related cardiovascular disorders. In this inflamed setting, PVAT is an important player in regulating vascular function in both autocrine and paracrine manners. 21 PVAT is the fat tissue surrounding blood vessels (both artery and vein) 44 that was long believed to be simply lipid-rich connective tissue, serving primarily as a supporting scaffold for blood vessels. In rodents, the mesenteric, carotid, and femoral arteries are surrounded by white adipose tissue, whereas the thoracic aorta is surrounded by brown adipose tissue, and the abdominal aorta is surrounded by beige PVAT (mixture of white and brown adipocytes). 45 Recent findings that PVAT inflammation potentially exacerbates endothelial dysfunction and atherosclerosis have led to an outside-in model of vascular injury. In this model, PVAT inflammation triggers an inward cascade from adventitia to endothelium. 46 We chose and modified the well-developed FeCl 3 -induced artery injury model-widely used to examine thrombus formation 40 -in an attempt to maximally mimic how a PVAT-triggered cascade of events might affect ensuing vascular dysfunction. By using less FeCl 3 (5%) than in most thrombosis models (10%), applied directly on the adventitia with intact PVAT via soaked filter paper, the Fe 3+ will cause major oxidative stress with the generation of reactive oxygen species and, in turn, lead to lipid peroxidation and destruction of endothelial cells. 40, 47 Our data highlight that x3 PUFAs efficiently generated in fat-1 mice were potent to mitigate chronic FeCl 3 -initiated vascular inflammatory cascades by reducing macrophage infiltration into the intima and PVAT and by limiting smooth muscle cell proliferation over 4 weeks. In contrast, x3 PUFAs were nearly without effect in compound Ffar4 À/À /fat-1 mice lacking the x3 fatty acid receptor FFAR4. Along with these in vivo results, in vitro activation of FFAR4 via x3 PUFAs prevents macrophages from propagating innate immune response by decreasing levels of proinflammatory cytokines and other lipid mediators. 15, 16, 18 Researchers have transplanted different types of PVAT to address their roles during atherosclerosis 48 and neointimal hyperplasia 49 ; however, transplanted PVAT disturbs the microenvironment surrounding the artery and potentially introduces immune responses to the foreign tissues. Further study will be necessary to address the precise cellular phenotypes of the PVAT in the mice used in our studies. The wire-injury model is another standard model for studying vascular remodeling 50 that
follows an "inside-out" paradigm in which endothelial injury initiates inflammatory signals and recruits blood-borne immune cells to the endothelium. It will be interesting to test the mice used in our studies with this particular model. Obesity and its associated risks of chronic inflammation result in exacerbation of cardiovascular disease. Loss of murine FFAR4 caused increased body weight and obesityrelated inflammation in the context of a high-fat diet (60% fat), and this is mirrored in humans. 13, 14 In line with these findings, disruption of FFAR4 likely promoted adipogenesis and increased fat accumulation in both epididymal and subcutaneous adipose tissues when fed with the x6 PUFA diet with 22% fat in our studies. Interestingly, Ffar4 À/À mice did not gain more weight than WT counterparts. Moreover, transgenic fat-1 mice were slightly leaner than WT mice in early life; this may relate to the antiadipogenic effect of x3 PUFAs during Figure 3 . Body weight, tissue weight, and food intake of mice on an omega-6 (x6) PUFA diet. A and B, Body weight changes of male and female mice were monitored twice a week when they were fed a diet rich in x6 fatty acids (22% fat). C and D, Food consumption per day of male and female mice was averaged weekly over the course of 8 weeks. No significant differences were detected. E, There was no difference in body weights between 4 strains of mice at %20 weeks of age. /fat-1 mice with the ability to directly convert x6 to x3 PUFA, 22 instead of supplementing diets with fish oil or x3 PUFA for which taste issues and oxidative destruction of the diet can be problems, allows for "cleaner" assessment of this G proteincoupled receptor to vascular-specific roles played by x3 PUFAs in the body. In this study, the ratio of x6/x3 PUFAs is higher in all 4 groups of mice, and the relative percentages of converted x3 PUFAs in fat-1 mice is likely lower than those in diet-supplementation studies. 52, 53 . This result might be expected because mice were fed a x6 PUFA diet, and the conversion efficiency of x3 fatty acid desaturase may be limited. The ratio of x3 PUFAs for fat-1 and WT mice (%5) in our study is much higher than that in fish oil-supplemented diet studies, 53 allowing us to address the effects of endogenously synthesized x3 PUFAs in mice with the fat-1 gene. Tissue-and cell-specific FFAR4 knockout strains should further enhance insight into the roles of this receptor in future studies. Dietary x3 PUFAs derived from fish oil were reported to inhibit platelet aggregation 54, 55 ; however, this scenario was not likely in our current studies because FFAR4 was not found in platelets. Without FFAR4 receptors on platelets, how could x3
PUFAs exert antithrombotic effects in fat-1 mice? We hypothesize that FFAR4 mediates inhibitory effects of x3 PUFAs on platelet accumulation at sites of induced injury, presumably, through dampening initial stages of vascular inflammation triggered by FeCl 3 and reactive oxygen species but not through blocking of interactions between platelets and endothelial cells. Absence of FFAR4 in platelets does not necessarily mean the absence of the effects of x3 PUFAs on platelets. We showed previously that x3 PUFA-rich fish oils favorably attenuate neointimal hyperplasia and improve cardiovascular function (platelet activity, blood pressure) by means of aspirin-triggered resolvins. 53 x3 PUFAs can also stimulate the generation of adiponectin through interaction with specific adipocyte channels 56 and may protect blood vessels from outside-in damage in the pathogenesis of cardiovascular disorders. Furthermore, we Because FFAR4 is expressed in circulating lymphocytes and resident peritoneal macrophages, it is possible that modulated immune activation of these cells by mediators such as prostaglandin E 2 could indirectly influence the artery wall and surrounding PVAT. Long-chain x3 PUFAs such as DHA, EPA, and a-linolenic acid detected in fat-1 mice have all been reported to activate FFAR4. 37, [58] [59] [60] In our current study, we were unable to discern which of these was most efficacious or whether the effects presented were the combined contribution of all x3 PUFAs in the body. Alternative pathways can explain the beneficial actions of x3 PUFAs, including generation of DHA-and/or EPA-derived specialized proresolving mediators. 61 DHAderived resolvin D1 or neuroprotectin specialized proresolving mediators confer anti-inflammatory and proresolving actions in inflamed tissues. 62, 63 Resolvin D2 given to mice within 4 hours after burn effectively prevented thrombosis of the deep dermal vascular network. 64 Resolvin E1 in human whole blood inhibits leukocyte activation and rolling by regulating rapid L-selectin shedding and selectively blocks ADP-stimulated platelet aggregation. 65 Although specialized proresolving mediators may mediate some of the salutary actions of x3 PUFAs, they do not appear to act via FFAR4. In summary, the in vivo data presented combined with our previous in vitro data 15 support a mechanism by which activation of the x3 PUFA-FFAR4 axis results in fewer detrimental effects on postinjury blood flow, reduced neointimal hyperplasia, and limited macrophage migration. A growing number of studies support the unique role of FFAR4 in modulating inflammation and mitigating obesity. It will be interesting to investigate the role of FFAR4 activation in the pathological process of arterial thrombosis and atherosclerosis in the context of obesity, insulin resistance, and other metabolic disorders. Our investigations pave the way for better understanding of the x3 PUFA-FFAR4 pathway and crosstalk of perivascular and vascular cells in cardiovascular disorders. In the long term, this research should shed light on cardiovascular inflammatory cascades and will provide novel therapeutic evidence for x3 PUFAs and possibly FFAR4 agonists for the management of vascular events.
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